NYSE · Surgical & Medical Instruments & Apparatus
14 entities across 14 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-25 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Penumbra Europe GmbH | Germany | |
| Penumbra Neuro Australia Pty Ltd | Australia | |
| Penumbra Neuro Canada Inc. | Canada | |
| Penumbra Latin America Distribuidora de Equipamentos e Produtos Médicos Ltda. | Brazil | |
| Crossmed S.p.A. | Italy | |
| Penumbra Interventional Therapies UK Ltd. | United Kingdom | |
| Penumbra Singapore Pte. Ltd. | Singapore | |
| Penumbra France SAS | France | |
| Penumbra Japan GK | Japan | |
| Penumbra Israel Ltd | Israel | |
| Penumbra Sweden AB | Sweden | |
| Penumbra Denmark ApS | Denmark | |
| Penumbra Marketing MEA FZE | United Arab Emirates | |
| Penumbra Poland sp. z o.o. | Poland |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $560.4M | −$15.7M | −$58.0M | 60.3% | 35,766,892 |
| FY2021 | $747.6M | $5.3M | −$11.7M | 63.6% | 37,881,180 |
| FY2022 | $847.1M | −$2.0M | −$75.0M | 63.2% | 37,841,874 |
| FY2023 | $1.1B | $91.0M | $82.1M | 64.5% | 39,216,564 |
| FY2024 | $1.2B | $14.0M | $147.3M | 63.2% | 39,268,037 |
| FY2025 | $1.4B | $177.7M | $174.9M | 67.1% | 39,291,828 |
16 institutions tracked — 9 added, 5 reduced, 2 opened a new position, 2 sold out.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | Active fund | 1,071,454 | +668,835 | $338.6M |
| FMR LLC | Active fund | 211,002 | −285,105 | $66.6M |
| CITADEL ADVISORS LLC | Hedge fund | 501,663 | +248,938 | $158.4M |
| MORGAN STANLEY | Active fund | 591,824 | +190,468 | $186.9M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 79,500 | +77,340 | $25.1M |
| STATE STREET CORP | Index | 1,243,258 | +57,447 | $392.6M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 31,776 | −45,588 | $10.0M |
| BlackRock, Inc. | Index | 4,297,555 | −32,901 | $1.4B |
| Capital World Investors | Active fund | 479,701 | +28,886 | $151.5M |
| Bridgewater Associates, LP | Hedge fund | 1,580 | −8,458 | $498,885 |
| BANK OF AMERICA CORP /DE/ | Active fund | 266,017 | +6,242 | $84.0M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 44,624 | +2,704 | $14.1M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 20,388 | −1,407 | $6.4M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 796,471 | +1,023 | $251.5M |
NORGES BANK, Point72 Asset Management, L.P. hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Penumbra Inc files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
